MLICM
CRDO icon

Metropolitan Life Insurance Company (MetLife)’s Credo Technology Group CRDO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CRDO Stock Details CRDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,572
Closed -$139K – 500
2024
Q1 		$139K Buy
6,572
+9
+0.1% +$188 0.01% 880
2023
Q4 		$128K Buy
6,563
+851
+15% +$14.5K 0.01% 955
2023
Q3 		$87.1K Buy
5,712
+405
+8% +$6.39K ﹤0.01% 1089
2023
Q2 		$92K Buy
+5,307
New +$63.1K ﹤0.01% 1056
2023
Q1 		– Sell
-6,017
Closed -$80.1K – 2344
2022
Q4 		$80.1K Hold
6,017
– – ﹤0.01% 1185
2022
Q3 		$66.2K Buy
6,017
+4,326
+256% +$57K ﹤0.01% 1273
2022
Q2 		$19.8K Hold
1,691
– – ﹤0.01% 2059
2022
Q1 		$25.8K Buy
+1,691
New +$24.6K ﹤0.01% 1972

Other funds holding CRDO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CRDO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Credo Technology Group (CRDO) in Q2 2024, closing a stake of 6,572 shares — an estimated $139K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CRDO in Q1 2022 and held it in 8 quarters. The position peaked at $139K in Q1 2024. 251 funds tracked by Wall St. Rank hold CRDO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Credo Technology Group position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,572 Credo Technology Group shares in Q2 2024, an estimated $139K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Credo Technology Group in Q1 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Credo Technology Group position peaked at $139K in Q1 2024.
  • 251 funds tracked by Wall St. Rank held Credo Technology Group as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.